fingolimod hydrochloride has been researched along with plitidepsin in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (plitidepsin) | Trials (plitidepsin) | Recent Studies (post-2010) (plitidepsin) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 129 | 23 | 51 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asif, M; Khalid, SH; Khan, IU; Khaniabadi, PM; Oon, CE; Saadullah, M; Saleem, M; Yaseen, HS; Yehya, AH; Zubair, HM | 1 |
1 other study(ies) available for fingolimod hydrochloride and plitidepsin
| Article | Year |
|---|---|
Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection.
Topics: Alkaloids; Anti-Inflammatory Agents; Antiviral Agents; COVID-19 Drug Treatment; Depsipeptides; Fingolimod Hydrochloride; Humans; Lectins; Marine Biology; Molecular Docking Simulation; Oceans and Seas; Peptides, Cyclic; Phycocyanin; Phytochemicals; Plant Lectins; Polyphenols; Polysaccharides; SARS-CoV-2; Seaweed; Sesquiterpenes | 2021 |